| Small-cell lung cancer is still a problem |
| D Bergsagel and R Feld |
|
JCO Nov 1 1984: 1189–1191.
[PDF]
|
 |
|
Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs |
| |
JR Daniels, LY Chak, BI Sikic, P Lockbaum, M Kohler, SK Carter, R Reynolds, R Bohnen, D Gandara, and J Yu |
| |
JCO Nov 1 1984: 1192–1199.
[Abstract]
[PDF]
|
|
|
Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report |
| |
CA Perez, L Einhorn, RK Oldham, FA Greco, HJ Cohen, H Silberman, S Krauss, N Hornback, F Comas, and G Omura |
| |
JCO Nov 1 1984: 1200–1208.
[Abstract]
[PDF]
|
|
|
The effect of specific and nonspecific immunotherapy on natural killer cell activity in patients with non-small-cell lung cancer |
| |
JA Maroun, HF Pross, TH Stewart, MJ White, and DB Hyslop |
| |
JCO Nov 1 1984: 1209–1214.
[Abstract]
[PDF]
|
|
|
In vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4'-O-tetrapyranyl-doxorubicin: correlations with clinical responses |
| |
V Georgoulias, YL Iskandar, F Amesland, P Ribaud, G Mathe, and C Jasmin |
| |
JCO Nov 1 1984: 1215–1222.
[Abstract]
[PDF]
|
|
|
Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma |
| |
FL Meyskens, Jr, L Loescher, TE Moon, B Takasugi, and SE Salmon |
| |
JCO Nov 1 1984: 1223–1228.
[Abstract]
[PDF]
|
|
|
Malignant melanoma in childhood: clinical course and response to chemotherapy |
| |
FA Hayes and AA Green |
| |
JCO Nov 1 1984: 1229–1234.
[Abstract]
[PDF]
|
|
|
Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration |
| |
RK Oldham, KA Foon, AC Morgan, CS Woodhouse, RW Schroff, PG Abrams, M Fer, CS Schoenberger, M Farrell, and E Kimball |
| |
JCO Nov 1 1984: 1235–1244.
[Abstract]
[PDF]
|
|
|
5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract |
| |
JH Harvey, FP Smith, and PS Schein |
| |
JCO Nov 1 1984: 1245–1248.
[Abstract]
[PDF]
|
|
|
Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma |
| |
CG Moertel, DS Childs, JR O'Fallon, MA Holbrook, AJ Schutt, and RJ Reitemeier |
| |
JCO Nov 1 1984: 1249–1254.
[Abstract]
[PDF]
|
|
|
Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor |
| |
PF Engstrom, PT Lavin, CG Moertel, E Folsch, and HO Douglass, Jr |
| |
JCO Nov 1 1984: 1255–1259.
[Abstract]
[PDF]
|
|
|
A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer |
| |
ET Creagan, SJ Green, DL Ahmann, JN Ingle, JH Edmonson, and RF Marschke, Jr |
| |
JCO Nov 1 1984: 1260–1265.
[Abstract]
[PDF]
|
|
|
Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion |
| |
WD Kaplan, SE Come, RW Takvorian, SM Laffin, RS Gelman, GR Weiss, and MB Garnick |
| |
JCO Nov 1 1984: 1266–1269.
[Abstract]
[PDF]
|
|
|
Sudden death in cancer patients receiving lithium |
| |
GH Lyman, CC Williams, WR Dinwoodie, and DD Schocken |
| |
JCO Nov 1 1984: 1270–1276.
[Abstract]
[PDF]
|
|
|
Totally implantable system for peritoneal access |
| |
CE Pfeifle, SB Howell, M Markman, and WE Lucas |
| |
JCO Nov 1 1984: 1277–1280.
[Abstract]
[PDF]
|
|
| The importance of dose intensity in chemotherapy of metastatic breast cancer |
| W Hryniuk and H Bush |
|
JCO Nov 1 1984: 1281–1288.
[PDF]
|
|
|
Continuous infusion chemotherapy: a critical review |
| |
NJ Vogelzang |
| |
JCO Nov 1 1984: 1289–1304.
[Abstract]
[PDF]
|
|
| Multiple primary malignancies |
| RS Hoffman, AH Rossof, R Pazdur, and RE Slayton |
|
JCO Nov 1 1984: 1305.
[PDF]
|
|
